Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of Population Pharmacokinetics-Guided Targeted Dosing of Anti-Thymocyte Globulin (ATG) in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation

NCT07862127 is registered in ClinicalTrials.gov with Daihong Liu as lead sponsor.

NCT NCT07862127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07862127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of Population Pharmacokinetics-Guided Targeted Dosing of Anti-Thymocyte Globulin (ATG) in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation
Lead sponsor
Daihong Liu
Phase
Phase 3
Overall status
Recruiting
Start date
August 1, 2026
Completion date
August 1, 2028
Enrollment
324 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic stem cell transplantation